Search Results - "Dobo, K."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development by Dobo, Krista L., Greene, Nigel, Cyr, Michelle O., Caron, Stéphane, Ku, Warren W.

    Published in Regulatory toxicology and pharmacology (01-04-2006)
    “…Starting materials and intermediates used to synthesize pharmaceuticals are reactive in nature and may be present as impurities in the active pharmaceutical…”
    Get full text
    Journal Article
  3. 3

    An evaluation of the sensitivity of the Ames assay to discern low-level mutagenic impurities by Kenyon, Michelle O., Cheung, Jennifer R., Dobo, Krista L., Ku, Warren W.

    Published in Regulatory toxicology and pharmacology (01-06-2007)
    “…Low level impurities often reside in active pharmaceutical ingredients (API). Some of these impurities are potentially genotoxic since reactive intermediates…”
    Get full text
    Journal Article
  4. 4

    The influence of cellular apoptotic capacity on N-nitrosodimethylamine-induced loss of heterozygosity mutations in human cells by DOBO, K. L, EASTMOND, D. A, GROSOVSKY, A. J

    Published in Carcinogenesis (New York) (01-09-1997)
    “…The induction of loss of heterozygosity (LOH) by the environmental carcinogen N-nitrosodimethylamine (NDMA), and the factors that influence the recovery of LOH…”
    Get full text
    Journal Article
  5. 5

    Sequence specific mutations induced by N-nitrosodimethylamine at two marker loci in metabolically competent human lymphoblastoid cells by DOBO, K. L, EASTMOND, D. A, GROSOVSKY, A. J

    Published in Carcinogenesis (New York) (01-05-1998)
    “…N-Nitrosodimethylamine (NDMA) is a potent mutagen and animal carcinogen to which many people are exposed through the consumption of contaminated food and the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human lymphoblasts by Dobo, K L, Giver, C R, Eastmond, D A, Rumbos, H S, Grosovsky, A J

    Published in Mutagenesis (01-01-1995)
    “…In order to investigate the influence of loss of heterozygosity (LOH) events on mutation rate, we studied two closely related human lymphoblastoid cell lines,…”
    Get more information
    Journal Article
  8. 8

    Role of oxygen radicals in the chromosomal loss and breakage induced by the quinone-forming compounds, hydroquinone and tert-butylhydroquinone by Dobo, K L, Eastmond, D A

    “…The mechanisms by which two quinone-forming compounds, hydroquinone (HQ) and tert-butyl-hydroquinone (tBHQ), induce chromosomal loss and breakage in a…”
    Get more information
    Journal Article
  9. 9

    Isolation and characterization of an R-prime plasmid from Rhizobium meliloti by Kiss, G B, Dobo, K, Dusha, I, Breznovits, A, Orosz, L, Vincze, E, Kondorosi, A

    Published in Journal of Bacteriology (1980)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10

    A Strategy for the Risk Assessment of Human Genotoxic Metabolites by Dobo, Krista L, Obach, R. Scott, Luffer-Atlas, Debra, Bercu, Joel P

    Published in Chemical research in toxicology (01-02-2009)
    “…The role of metabolism in genotoxicity and carcinogenicity of many chemicals is well established. Accordingly, both in vitro metabolic activation systems and…”
    Get full text
    Journal Article
  11. 11

    Overview of Genotoxic Impurities in Pharmaceutical Development by Bercu, Joel P., Dobo, Krista L., Gocke, Elmar, McGovern, Timothy J.

    Published in International Journal of Toxicology (01-11-2009)
    “…This symposium focuses on the management of genotoxic impurities in the synthesis of pharmaceuticals. Recent developments in both Europe and United States…”
    Get full text
    Book Review Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16